UiPath Q1 2027 Earnings Preview: Key Metrics and Options Trading Strategies Near 52-Week Lows

$UiPath(PATH)$ is scheduled to report its fiscal Q1 2027 earnings on Thursday, May 28, 2026, after the market closes.

The stock has been carved up over the past year, hovering near its 52-week lows around $11. Investors are grappling with a massive narrative shift: UiPath has successfully pivoted to profitability, but its top-line hyper-growth has decelerated into the low double digits.

Here is a comprehensive look at the key metrics to watch and how to frame potential short-term trading opportunities around the release.

The Baseline: What Wall Street Expects

UiPath provided very explicit boundaries during its Q4 earnings call. The numbers to check against the headline print are:

Revenue Guidance: $395 million to $400 million (Consensus estimate sits right in the middle at $397.5 million).

Adjusted EPS Consensus: $0.16.

ARR (Annualized Renewal Run-Rate) Target: $1.894 billion to $1.899 billion as of April 30, 2026.

Non-GAAP Operating Income: Positioned to hit near $80 million for the single quarter.

UiPath (PATH) reported its fiscal Q4 and full-year 2026 financial results on March 11, 2026. The report showed a company executing exceptionally well on internal efficiencies and cash generation, yet struggling to shake a broader market narrative that its core product face long-term risk from generative AI.

Here is the breakdown of the Q4 print and the heavy operational lessons the market extracted from their forward guidance.

The Q4 2026 Scorecard: A Quietly Historic Quarter

By almost all backward-looking metrics, UiPath delivered a highly successful quarter, highlighted by a major financial milestone.

Key Financial Highlights

• Revenue: $481 million, up 14% year-over-year, beating Wall Street estimates of $465 million.

• Annual Recurring Revenue (ARR): Reached $1.853 billion, an 11% year-over-year increase, driven by $70 million in net new ARR additions during the quarter.

• Non-GAAP EPS: $0.30, coming in ahead of the $0.25 analyst consensus estimate.

• The Profitability Milestone: UiPath achieved full-year GAAP profitability for the first time in company history, posting full-year GAAP net income of $282 million. Q4 GAAP operating income alone was $80 million (17% margin).

• Free Cash Flow & Capital Returns: The company generated $182 million in adjusted free cash flow for the quarter ($372 million for the full year). Backed by a $1.69 billion cash pile, management finished their $1 billion buyback program and authorized a fresh $500 million share repurchase program.

Customer & AI Metrics

• Dollar-Based Net Retention Rate (NRR): Stood at 107% (106% adjusted for currency).

• Large Customers: Customers with more than $100k in ARR grew to 2,565, and those over $1 million grew to 357.

• AI Monetization: Management noted that AI products contributed nearly $200 million to total ARR, revealing that 90% of their $1 million-plus clients are already utilizing their AI offerings.

The Market's Reaction: Why the Stock Slipped

Despite beating top and bottom-line estimates and scaling up buybacks, the stock fell roughly 6% the following morning. The culprit was soft forward guidance and structural headwinds hidden in the outlook.

For the full year fiscal 2027, UiPath guided:

• FY27 Revenue: $1.754 billion to $1.759 billion (implying a deceleration to ~10% growth).

• FY27 ARR: $2.051 billion to $2.056 billion.

3 Core Lessons Learned From the Guidance

The guidance drop offered a stark textbook lesson on how Wall Street values enterprise software companies in the age of generative AI.

1. The Value Re-Pricing Trap (Growth vs. Margin)

The primary takeaway is that management has actively chosen a path of operating discipline over hyper-growth, and the market is re-pricing the stock accordingly. Management raised its long-term non-GAAP operating margin target to 30% (up from 23%).

While building a highly profitable, cash-flowing fortress is excellent, Wall Street values mid-cap software on top-line expansion momentum. Guiding to 10% revenue growth tells investors that the days of UiPath as a premium-multiple "growth darling" are officially over; it is now priced as an efficient, low-multiple value play.

2. The Cloud/SaaS Transition Generates Growth Headwinds

Management explicitly noted that their shift toward Software-as-a-Service (SaaS) and cloud models would act as a 1% headwind to total revenue growth for fiscal 2027. When enterprise software firms migrate clients from upfront on-premise term licenses to consumption- or cloud-based models, revenue recognition smooths out over time rather than hitting all at once. This creates a temporary statistical drag on revenue, forcing investors to focus entirely on ARR to find the ground truth.

3. The "AI Disruption" Discount Is Hard to Shake

The guidance proved that even though UiPath is successfully cross-selling AI features (generating $200 million in ARR), it isn't causing an immediate acceleration in overall contract values.

The enterprise software market is going through an optimization phase. Corporate buyers are asking: "Why should I pay for large-scale Robotic Process Automation (RPA) seats if LLM-powered autonomous AI agents can eventually write code or handle tasks natively?" UiPath’s cautious guide tells us that closing large, multi-year automation platform deals takes significantly longer now, as customers carefully evaluate their long-term AI architecture before signing.

3 Core Metrics Investors are Watching

While beating the numbers above provides a knee-jerk reaction, the actual direction of the post-earnings trend will be driven by three structural items:

1. Net New ARR & Net Retention Rate (NRR)

Because UiPath relies on a subscription model, revenue can lag. ARR is the truest health indicator.

• At the end of FY2026, ARR stood at $1.853 billion (up 11% year-over-year). To meet their Q1 guidance, they need to add roughly $41 million to $46 million in net new ARR.

• Watch the Dollar-Based Net Retention Rate. It recently clocked in at 107%. If this slips closer to 105% or lower, it implies existing enterprise clients are optimization-focused rather than expansion-focused, which will spook growth investors.

2. The Agentic AI Monetization Proof

UiPath recently launched its Agentic Automation Platform and rolled out consumption-based, usage-based pricing models. Management noted that AI products accounted for roughly $200 million of their ARR.

• The market is deeply skeptical about whether traditional Robotic Process Automation (RPA) companies will be disrupted by modern LLM AI agents, or if they will lead the transition. Look for commentary or metrics showing how quickly enterprise customers are upgrading to the agentic platform.

3. Full-Year FY2027 Guidance Reassurance

For the full year, UiPath previously guided revenue to $1.754 billion–$1.759 billion (representing ~10% growth). Because software valuations have been punished heavily for lowering full-year outlooks, any downward revision to the full-year ARR guide ($2.051B to $2.056B) will cause a severe drop, regardless of how good Q1 looks.

UiPath (PATH) Price Target

Based on 17 analysts from Tiger Brokers app offering 12 month price targets for UiPath in the last 3 months. The average price target is $13.50 with a high forecast of $17.00 and a low forecast of $10.98. The average price target represents a 21.69% change from the last price of $11.09.

Short-Term Trading Opportunities

From a trading perspective, PATH has a fascinating setup: It has very compressed valuation multiples but a massive short interest footprint (~23.6%). This makes it an ideal candidate for a high-volatility binary play, though directional risk is intense.

Scenario A: The Bullish "Short Squeeze / Value Mean Reversion"

If UiPath prints a clean beat, holds or slightly raises full-year guidance, and proves that agentic AI adoption is accelerating, the stock could experience a violent upside move.

• The Setup: With the stock around $11.20, a push past the immediate resistance at $12.00 could spark a rapid short covering rally toward $13.50–$14.00 (the average consensus analyst price target).

• Options Strategy Idea: A defined-risk Bull Put Spread (selling a put at a strike like $10 or $10.50 and buying one at $9 or $9.50) allows you to capture high implied volatility (IV) crush post-earnings, as long as the stock stays flat or moves up. Alternatively, a low-cost, out-of-the-money Call option or Call Spread leverages a major squeeze without risking massive capital.

Scenario B: The Bearish "Growth Slowdown Trap"

If NRR continues to compress, enterprise spending looks weak, or consumption pricing adoption stalls, the market will treat PATH as a legacy tech play.

• The Setup: A failure to secure its full-year guidance could easily cause the stock to break below its 52-week low ($9.20) and re-test single digits.

• Options Strategy Idea: Implied volatility will be at an annual peak right before the closing bell on May 28. Buying straight Puts is expensive due to "IV crush" immediately after the announcement. A Bear Call Spread (selling a higher strike call, buying an even higher one for protection) allows a trader to profit from a flat-to-downside move while benefiting from the post-earnings volatility collapse.

Scenario C: The Pure Volatility Play (Long Straddle / Strangle)

Because of the heavy short interest and critical macro crossroads for AI software, this earnings call is unlikely to be quiet.

• The Setup: If you expect a massive double-digit move but have no directional conviction, a Long Strangle (buying an out-of-the-money Call and Put simultaneously) wins if the stock moves violently in either direction. However, because options premiums are inflated before the print, the move must exceed the market's implied move (usually around 12–15% for PATH) to yield a profit.

Position sizing is everything on a stock like this; binary events can see rapid changes in option values within the first minutes of the opening bell on Friday morning.

Summary

UiPath (PATH) will report its fiscal Q1 2027 earnings on Thursday, May 28, 2026, after the market closes. Currently hovering near its 52-week lows around $11, the stock faces a critical narrative shift as its hyper-growth slows down despite its strong turn toward profitability.

The Baseline Numbers

Wall Street expects a tightly bounded quarter, aligning directly with management's previous targets:

• Revenue Consensus: $397.5 million (Guidance: $395M – $400M).

• Adjusted EPS Consensus: $0.15.

• ARR Target: $1.894 billion to $1.899 billion.

Key Metrics to Watch

1. Net New ARR: To hit targets, UiPath needs to add $41 million to $46 million in net new ARR. Investors will heavily scrutinize the Dollar-Based Net Retention Rate (NRR), which stood at 107% last quarter. Any drop toward 105% reveals that existing enterprise clients are optimizing budgets rather than expanding software seats.

2. Agentic AI Adoption: Traditional Robotic Process Automation (RPA) faces intense skepticism from modern LLM software agents. Investors want proof that UiPath's newly launched Agentic Automation Platform and its consumption-based pricing models are gaining actual traction.

3. Full-Year FY2027 Reassurance: Software valuations are currently being severely punished for lowering full-year forecasts. UiPath previously guided full-year ARR to $2.051B–$2.056B. A downward revision here will likely trigger a massive sell-off.

Short-Term Trading Opportunities

With a highly compressed valuation and an exceptionally large short interest (~23.6%), the stock is primed for a high-volatility, binary post-earnings move:

• The Squeeze (Bullish): If UiPath delivers a clean ARR beat and reassures the market on AI adoption, the stock could clear immediate $12 resistance and trigger a rapid short-covering squeeze toward $13.50. Traders can utilize a defined-risk Bull Put Spread to capitalize on the post-earnings implied volatility (IV) crush.

• The Growth Trap (Bearish): A soft outlook or weak NRR will reinforce fears that AI is disrupting RPA. This could easily break its 52-week low ($9.20). Because outright Puts will be expensive due to inflated pre-earnings IV, a Bear Call Spread offers a cleaner way to profit from a flat-to-downside move.

• Pure Volatility (Direction Neutral): If a massive double-digit move is expected but direction is unclear, a Long Strangle captures major price swings, provided the breakout exceeds the market's implied 12–15% move.

Appreciate if you could share your thoughts in the comment section whether you think PATH could improve its ARR and provide a better opportunities for option trading.

@TigerStars @Daily_Discussion @Tiger_Earnings @TigerWire @MillionaireTiger appreciate if you could feature this article so that fellow tiger would benefit from my investing and trading thoughts.

Disclaimer: The analysis and result presented does not recommend or suggest any investing in the said stock. This is purely for Analysis.